Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma
Aim. To assess prognostic value of surrogate clinical and laboratory markers in current therapy of multiple myeloma (MM). Materials & Methods. The analysis included 567 patients (215 men and 352 women), the Kirov region inhabitants with newly diagnosed MM over the period from January 1, 1994...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Practical Medicine Publishing House
2018-04-01
|
| Series: | Kliničeskaâ onkogematologiâ |
| Subjects: | |
| Online Access: | http://bloodjournal.ru/wp-content/uploads/2018/03/6.pdf |